Amicus Therapeutics Inc.

NASDAQ: FOLD · Real-Time Price · USD
6.16
0.20 (3.36%)
At close: Jun 06, 2025, 3:59 PM
6.13
-0.41%
After-hours: Jun 06, 2025, 06:49 PM EDT

Amicus Therapeutics Revenue

Amicus Therapeutics reported an annual revenue of $528.29M, reflecting a 32.29% growth. For the quarter ending March 31, 2025, Amicus Therapeutics generated $125.25M in revenue.
Revenue (ttm)
$528.29M
Revenue Growth
32.29%
Price / Sales Ratio
5.43
Revenue / Employee
$1.06M
Employees
499
Market Cap
1.9B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.